|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 39 | 2020 | The importance of dose optimisation in the treatment of iron deficiency in heart failure | MARTENS, Pieter; Minten, Lennert; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 40 | 2020 | Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first-in-human study | MULLENS, Wilfried; Sharif, Faisal; DUPONT, Matthias; Rothman, Alexander M. K.; Wijns, William | Journal Contribution | A1 |
| 41 | 2020 | Optimum Blood Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest | AMELOOT, Koen; Jakkula, Pekka; Haestbacka, Johanna; Reinikainen, Matti; Pettila, Ville; Loisa, Pekka; Tiainen, Marjaana; Bendel, Stepani; Birkelund, Thomas; Belmans, Ann; Palmers, Pieter-Jan; BOGAERTS, Eric; Lemmens, Robin; DE DEYNE, Cathy; Ferdinande, Bert; DUPONT, Matthias; Janssens, Stefan; DENS, Jo; Skrifvars, Markus B. | Journal Contribution | A1 |
| 42 | 2020 | Heart failure is associated with accelerated age related metabolic bone disease | MARTENS, Pieter; ter Maaten, Jozine M.; Vanhaen, Dimitri; HEEREN, Georges; Caers, Thalissa; Bovens, Becky; DAUW, Jeroen; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 43 | 2020 | Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes | MARTENS, Pieter; Janssens, Joyce; Ramaekers, Jobbe; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 44 | 2019 | Rationale and design of the IRONâCRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy | Somers, Frauke; Timmermans, Philippe; VERWERFT, Jan; DAUW, Jeroen; MULLENS, Wilfried; MARTENS, Pieter; DUPONT, Matthias; HERBOTS, Lieven | Journal Contribution | A1 |
| 45 | 2019 | The Optimal Plasma Volume Status in Heart Failure in Relation to Clinical Outcome | MARTENS, Pieter; NIJST, Petra; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 46 | 2019 | Feasibility of Neurohumoral Blocker Withdrawal in Patients Optimally Responding to Cardiac Resynchronization Therapy: An Open-label, Double Randomized Controlled Pilot Trial | NIJST, Petra; MARTENS, Pieter; DUPONT, Matthias; Voros, Gabor; Willems, Rik; Tang, W. H. Wilson; MULLENS, Wilfried | Journal Contribution | M |
| 47 | 2019 | Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction | MARTENS, Pieter; NUYENS, Dieter; Rivero-Ayerza, Maximo; Van Herendael, Hugo; Vercammen, Jan; Ceyssens, Wendy; Luwel, Evert; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 48 | 2019 | Effects of sacubitril/valsartan on functional status and exercise capacity in real-world patients | Lau, Chirik Wah; MARTENS, Pieter; Lambeets, Seppe; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 49 | 2019 | Impact of sacubitril/valsartan on heart failure admissions: insights from real-world patient prescriptions | MARTENS, Pieter; Lambeets, Seppe; Lau, Chirik Wah; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 50 | 2019 | Prevalence of underlying gastrointestinal malignancies in iron-deficient heart failure | MARTENS, Pieter; Minten, Lennert; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 51 | 2019 | Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure | MARTENS, Pieter; DUPONT, Matthias; VERBRUGGE, Frederik; Damman, Kevin; Degryse, Nicolas; NIJST, Petra; Reynders, Carmen; PENDERS, Joris; Tang, W. H. Wilson; Testani, Jeffrey; MULLENS, Wilfried | Journal Contribution | A1 |
| 52 | 2019 | Response to Cardiac Resynchronization Therapy Across Chronic Kidney Disease Stages | Ter Maaten, Jozine M.; MARTENS, Pieter; L'Hoyes, Wouter; Maass, Alexander H.; Damman, Kevin; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 53 | 2019 | Early goal-directed haemodynamic optimization of cerebral oxygenation in comatose survivors after cardiac arrest: the Neuroprotect post-cardiac arrest trial | AMELOOT, Koen; DE DEYNE, Cathy; EERTMANS, Ward; Ferdinande, Bert; DUPONT, Matthias; Palmers, Pieter-Jan; Petit, Tibaut; Nuyens, Philippe; MAEREMANS, Joren; Vundelinckx, Joris; Vanhaverbeke, Maarten; Belmans, Ann; Peeters, Ronald; Demaerel, Philippe; Lemmens, Robin; DENS, Jo; Janssens, Stefan | Journal Contribution | A1 |
| 54 | 2018 | Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low | VERBRUGGE, Frederik; MARTENS, Pieter; Boonen, Levinia; NIJST, Petra; Verhaert, David; NOYENS, Patrick; DE VUSSER, Philip; DUPONT, Matthias; Tang, W. H. Wilson; MULLENS, Wilfried | Journal Contribution | A1 |
| 55 | 2018 | Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial | MULLENS, Wilfried; VERBRUGGE, Frederik; NIJST, Petra; MARTENS, Pieter; Tartaglia, Katrien; THEUNISSEN, Evi; BRUCKERS, Liesbeth; Droogne, Walter; Troisfontaines, Pierre; Damman, Kevin; Lassus, Johan; Mebazaa, Alexandre; Filippatos, Gerasimos; Ruschitzka, Frank; DUPONT, Matthias | Journal Contribution | A1 |
| 56 | 2018 | Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology | MARTENS, Pieter; NIJST, Petra; VERBRUGGE, Frederik; DUPONT, Matthias; Tang, W. H. Wilson; MULLENS, Wilfried | Journal Contribution | A1 |
| 57 | 2018 | Dermal Interstitial Alterations in Patients With Heart Failure and Reduced Ejection Fraction A Potential Contributor to Fluid Accumulation? | NIJST, Petra; Olinevich, Mikhail; HILKENS, Petra; MARTENS, Pieter; DUPONT, Matthias; Tang, W. H. Wilson; LAMBRICHTS, Ivo; NOBEN, Jean-Paul; MULLENS, Wilfried | Journal Contribution | A1 |
| 58 | 2018 | Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction | MARTENS, Pieter; NIJST, Petra; VERBRUGGE, Frederik; Smeets, Kevin; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 59 | 2018 | The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction | MARTENS, Pieter; BELIEN, Hanne; DUPONT, Matthias; VANDERVOORT, Pieter; MULLENS, Wilfried | Journal Contribution | A1 |
| 60 | 2018 | Endovascular shedding markers in patients with heart failure with reduced ejection fraction: Results from a single-center exploratory study | NIJST, Petra; COPS, Jirka; MARTENS, Pieter; SWENNEN, Quirine; DUPONT, Matthias; Tang, Wai Hong W.; MULLENS, Wilfried | Journal Contribution | A1 |
| 61 | 2018 | Limited contractile reserve contributes to poor peak exercise capacity in iron-deficient heart failure | MARTENS, Pieter; VERBRUGGE, Frederik; NIJST, Petra; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 62 | 2018 | Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling A Cardiopulmonary Exercise Testing Imaging Evaluation | MARTENS, Pieter; VERBRUGGE, Frederik; BERTRAND, Philippe; Verhaert, David; VANDERVOORT, Pieter; DUPONT, Matthias; Tang, W. H. Wilson; Janssens, Stefan; MULLENS, Wilfried | Journal Contribution | A1 |
| 25 | 2018 | Effect of multidisciplinary cardiac rehabilitation on the response to cardiac resynchronization therapy | MARTENS, Pieter; Jacobs, Guy; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 26 | 2018 | The impact of global hemodynamics, oxygen and carbon dioxide on epileptiform EEG activity in comatose survivors of out-of-hospital cardiac arrest | Moonen, C.; Lemmens, Robin; Van Paesschen, W.; Wilmer, A.; EERTMANS, Ward; Ferdinande, Bert; DUPONT, Matthias; DE DEYNE, Cathy; DENS, Jo; Janssens, S.; AMELOOT, Koen | Journal Contribution | A1 |
| 27 | 2018 | Cardiac iron deficiency-how to refuel the engine out of fuel | MARTENS, Pieter; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A2 |
| 28 | 2018 | Value of routine investigations to predict loop diuretic down-titration success in stable heart failure | MARTENS, Pieter; VERBRUGGE, Frederik; Boonen, Levinia; NIJST, Petra; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 29 | 2018 | Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure | MARTENS, Pieter; Vercammen, Jan; Ceyssens, Wendy; Jacobs, Linda; Luwel, Evert; Van Aerde, Herwig; Potargent, Peter; Renaers, Monique; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 30 | 2018 | Insights into implementation of sacubitril/valsartan into clinical practice | MARTENS, Pieter; BELIEN, Hanne; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 31 | 2017 | Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions | MARTENS, Pieter; VERBRUGGE, Frederik; NIJST, Petra; DUPONT, Matthias; MULLENS, Wilfried | Journal Contribution | A1 |
| 32 | 2017 | Intravascular volume expansion in patients with heart failure and reduced ejection fraction is not revealed by changes in cardiac filling pressures | NIJST, Petra; MARTENS, Pieter; VERBRUGGE, Frederik; DUPONT, Matthias; Tang, Wilson; MULLENS, Wilfried | Journal Contribution | M |
| 33 | 2017 | Bioimpedance Alerts from Cardiovascular Implantable Electronic Devices: Observational Study of Diagnostic Relevance and Clinical Outcomes | SMEETS, Christophe; VRANKEN, Julie; Van der Auwera, Jo; VERBRUGGE, Frederik; MULLENS, Wilfried; DUPONT, Matthias; GRIETEN, Lars; DE CANNIERE, Helene; LANSSENS, Dorien; VANDENBERK, Thijs; STORMS, Valerie; THIJS, Inge; VANDERVOORT, Pieter | Journal Contribution | A1 |
| 34 | 2017 | Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator | MARTENS, Pieter; Verbrugge, Frederik H.; NIJST, Petra; DUPONT, Matthias; NUYENS, Dieter; Van Herendael, Hugo; Rivero-Ayerza, Maximo; Tang, Wilson H.; MULLENS, Wilfried | Journal Contribution | A1 |
| 35 | 2017 | Mean arterial pressure of 65 mm Hg versus 85-100 mm Hg in comatose survivors after cardiac arrest: Rationale and study design of the Neuroprotect post-cardiac arrest trial | AMELOOT, Koen; DE DEYNE, Cathy; Ferdinande, Bert; DUPONT, Matthias; Palmers, Pieter-Jan; Petit, Thibault; EERTMANS, Ward; Moonen, Clara; Belmans, Ann; Lemmens, Robin; DENS, Jo; Janssens, Stefan | Journal Contribution | A1 |
| 36 | 2017 | Feasibility and Association of Neurohumoral Blocker Up-titration After Cardiac Resynchronization Therapy | MARTENS, Pieter; VERBRUGGE, Frederik; NIJST, Petra; BERTRAND, Philippe; DUPONT, Matthias; Tang, Wilson H.; MULLENS, Wilfried | Journal Contribution | A1 |
| 37 | 2017 | Renal response to intravascular volume expansion in euvolemic heart failure patients with reduced ejection fraction: Mechanistic insights and clinical implications | NIJST, Petra; VERBRUGGE, Frederik; MARTENS, Pieter; DUPONT, Matthias; Tang, W. H. Wilson; MULLENS, Wilfried | Journal Contribution | A1 |
| 38 | 2017 | Dermal interstitial alterations in patients with heart failure and reduced ejection fraction are associated with volume status | NIJST, Petra; MARTENS, Pieter; HILKENS, Petra; Olinevic, M.; DUPONT, Matthias; Tang, W.; LAMBRICHTS, Ivo; NOBEN, Jean-Paul; MULLENS, Wilfried | Journal Contribution | M |
Loading...
5
0
5
0
false